Alpa Laboratories Limited

NSE:ALPA.NS

111.64 (INR) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2023202220212020201920182017201620152014201320122011201020092008
Revenue 1,087.39924.3621,105.133964.135848.704764.219613.193656.812535.9573.939567.083561.085551.299819.543934.3671,216.848
Cost of Revenue 898.495631.76760.872647.555552.752530.896398.332418.546307.192400.104366.458403.193431.241728.835844.9531,127.102
Gross Profit 188.895292.602344.261316.58295.952233.323214.861238.266228.708173.835200.625157.892120.05790.70889.41489.746
Gross Profit Ratio 0.1740.3170.3120.3280.3490.3050.350.3630.4270.3030.3540.2810.2180.1110.0960.074
Reseach & Development Expenses 0000000000000000
General & Administrative Expenses 010.77117.23122.03220.77918.81910.18613.40176.54585.2236.1876.051045.31746.60842.645
Selling & Marketing Expenses 051.60757.92644.87553.42550.03641.1799.0922.9152.85228.49619.1970000
SG&A 127.3862.37875.15766.90774.20468.85551.36522.49379.4688.075134.669105.017045.31746.60842.645
Other Expenses 148.89799.3271.4830.5161.0620.4670.0711.7930.7471.0830.150.2340.00518.15931.38736.096
Operating Expenses 127.38230.296248.849219.415250.805237.844194.493202.851145.517200.23234.457173.769104.38863.47677.99578.741
Operating Income 61.51567.61690.05874.04647.1192.401184.54935.41583.191-26.395-33.832-15.87715.6727.23111.41911.005
Operating Income Ratio 0.0570.0730.0810.0770.0560.0030.3010.0540.155-0.046-0.06-0.0280.0280.0330.0120.009
Total Other Income Expenses Net 145.30591.287105.56133.819-18.04425.162-138.3493.19314.183-0.722-15.681-16.249-7.314-16.413-1.2740.494
Income Before Tax 206.82159.399195.62107.86429.07525.38546.238.60897.374-27.117-49.513-32.1268.35510.81910.14511.499
Income Before Tax Ratio 0.190.1720.1770.1120.0340.0330.0750.0590.182-0.047-0.087-0.0570.0150.0130.0110.009
Income Tax Expense 39.05533.07554.70235.39410.54117.44618.429.30128.914-13.1412.03611.5543.0711.782.187.713
Net Income 167.765126.324140.91772.47118.5347.93927.99.30868.461-13.977-51.548-43.685.2859.0397.9653.786
Net Income Ratio 0.1540.1370.1280.0750.0220.010.0450.0140.128-0.024-0.091-0.0780.010.0110.0090.003
EPS 8.015.986.73.440.880.351.331.23.25-0.66-2.45-2.080.250.430.380.18
EPS Diluted 8.015.986.73.440.880.351.331.23.25-0.66-2.45-2.080.250.430.380.18
EBITDA 81.064174.917130.15112.489102.85570.57195.83116.319141.62460.03656.7631.40825.70142.16220.95825.466
EBITDA Ratio 0.0750.1890.1180.1170.1210.0920.1560.1770.2640.1050.10.0560.0470.0510.0220.021